Centessa Pharmaceuticals Plc ADR (CNTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Operating Expenses | 68,414 | 53,218 | 58,292 | 38,314 | 41,287 |
| Operating Income | -68,414 | -53,218 | -58,246 | -38,314 | -41,287 |
| Interest Expense | 1,653 | 1,500 | 1,281 | -65 | -27 |
| Other Income | 5,384 | 300 | -1,962 | -1,906 | -191 |
| Pre-tax Income | -64,683 | -54,418 | -61,489 | -40,155 | -41,451 |
| Income Tax | -22 | 80 | N/A | N/A | N/A |
| Net Income Continuous | -64,661 | -54,498 | -61,603 | -40,155 | -41,451 |
| Net Income | $-64,661 | $-54,498 | $-61,603 | $-40,155 | $-41,451 |
| EPS Basic Total Ops | -0.69 | -0.60 | 0.99 | -0.45 | -0.65 |
| EPS Basic Continuous Ops | -0.69 | -0.60 | 0.99 | -0.45 | -0.65 |
| EPS Diluted Total Ops | -0.69 | -0.60 | 0.99 | -0.45 | -0.65 |
| EPS Diluted Continuous Ops | -0.69 | -0.60 | 0.99 | -0.45 | -0.65 |
| EBITDA(a) | $-68,382 | $-53,190 | $-58,280 | $-38,301 | $-41,280 |